Home » Topics » BioWorld Science

BioWorld Science
RSS

Tiziana Life Sciences reports positive phase IIa data for milciclib in HCC

Sep. 5, 2019

CC-90011 demonstrates promising activity in models of SCLC

Sep. 5, 2019

Preclinical and phase I data presented for SAR-439859

Sep. 5, 2019

Discovery of novel R-PTP-sigma inhibitors to promote hematopoietic stem cell regeneration

Sep. 5, 2019

Soluble RANKL inhibition may prevent tumor metastasis to bone

Sep. 5, 2019

Antimalarial kinase inhibitor identified at the University of Glasgow

Sep. 5, 2019

CRISPR targets fat cells, improves metabolism

Sep. 5, 2019

Evaluation of the effects of atractylenolide I in a new mouse model of cancer cachexia

Sep. 5, 2019

JMJD6 predicts poor prognosis in ovarian cancer and can be a new therapeutic target

Sep. 5, 2019

InnoCare Pharma identifies TRK inhibitors

Sep. 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
Research grants support early clinical trials of ALS treatments
BioWorld Science
The ALS Association has announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support...